These results indicate that the Po-12-Cy5 probe has precise targeting of TIGIT in HCC and can be used as an indicator of RT immunoregulation, which has important clinical significance for guiding HCC immunotherapy. Here, TIGIT is linked to hepatocellular carcinoma.